ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Internal Medicine

Top Internal Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BRIAN BLANCHETTE MD

Internal Medicine

14,199

$606K

559
464 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $56

HABIBULLAH HABIBI M.D.

Internal Medicine

14,133

$700K

374
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $56

MINPING LIU M.D.

Internal Medicine

14,048

$1.31M

540
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

24%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$93
Average prescription price

Avg: $56

WILLIAM GAINES MD

Internal Medicine

14,044

$597K

695
621 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $56

ANIKET CHAKRABARTI M.D.

Internal Medicine

14,033

$753K

380
325 are 65+

17%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $56

GEORGE GAGNE M.D.

Internal Medicine

14,023

$775K

270
217 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

ABRAHAM DIETZ MD

Internal Medicine

14,000

$773K

630
565 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

KENNETH GUARNIERI M.D.

Internal Medicine

13,975

$706K

530
397 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

JAMES OCONNOR MD

Internal Medicine

13,947

$642K

455
410 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $56

ROHIT JANGI MD

Internal Medicine

13,885

$575K

383
367 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $56

WILLIAM MUGG MD

Internal Medicine

13,814

$704K

346
270 are 65+

19%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

FRANCO DESANTIS M.D.

Internal Medicine

13,770

$566K

775
563 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $56

BRIAN DALTON M.D.

Internal Medicine

13,622

$700K

497
363 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

ANTHONY SPOSATO MD

Internal Medicine

13,593

$770K

264
237 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $56

THOMAS VAUGHAN MD

Internal Medicine

13,593

$785K

503
416 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $56

ROBERT LEBOW M.D., FACP

Internal Medicine

13,471

$589K

427
261 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

MANJUL SHUKLA MD

Internal Medicine

13,343

$995K

527
416 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $56

ANTONIO MENDES M.D

Internal Medicine

13,271

$678K

265
163 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $56

MELVYN KRAMER M.D.

Internal Medicine

13,235

$953K

584
517 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $56

MARC THEROUX MD

Internal Medicine

13,209

$712K

427
357 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $56

JANARTHANAN SOMESWARANANTHAN MD

Internal Medicine

13,192

$602K

422
381 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $56

HARVEY REBACK MD

Internal Medicine

13,131

$719K

409
358 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $56

NIKOLAOS MICHALACOS MD

Internal Medicine

13,048

$601K

593
473 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $56

EHAB SORIAL M.D.

Internal Medicine

12,899

$586K

515
389 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $56

DEREK ILLASTRON MD

Internal Medicine

12,725

$558K

569
425 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank